Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Glenmark Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Glenmark Pharmaceuticals Ltd Share Price Chart
Glenmark Pharmaceuticals Ltd Fundamentals
Traded Volume: N/A
Market Cap(Cr): N/A
Avg Traded Price N/A
1 Year return %
Upper Circuit N/A
Lower Circuit N/A
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) N/A
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Glenmark Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Glenmark Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Glenmark Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W N/A%
1M N/A%
3M N/A%
1Y N/A%
YTD N/A%
Glenmark Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Glenmark Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Glenmark Pharmaceuticals Ltd Technical Details
Glenmark Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 N/A
Support 2 N/A
Support 3 N/A
Pivot Point : N/A
Resistance 1 N/A
Resistance 2 N/A
Resistance 3 N/A
Glenmark Pharmaceuticals Ltd Corporate Actions
Glenmark Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Glenmark Pharmaceuticals Ltd’s capital allocation strategies.
All
Dividends
Bonus
Splits
Others
Glenmark Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Glenmark Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Glenmark Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Glenmark Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Glenmark Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
Glenmark Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Glenmark Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Glenmark Pharmaceuticals Ltd
Company information not available.
Registered office , , , ,
FAX :
Background
Incorporation Year
Face Value ₹
Market Lot
FAQs on Glenmark Pharmaceuticals Ltd
How to buy Glenmark Pharmaceuticals Ltd shares on NSE?
To buy Glenmark Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Glenmark Pharmaceuticals Ltd share price today?
The Glenmark Pharmaceuticals Ltd share price on NSE is ₹N/A today.
What is the market cap of Glenmark Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹N/A.
What is the PE & PB ratio of Glenmark Pharmaceuticals Ltd?
PE is N/A and PB is N/A.
What is the 52 Week High and Low of Glenmark Pharmaceuticals Ltd shares?
Glenmark Pharmaceuticals Ltd stock price high: ₹N/A Glenmark Pharmaceuticals Ltd stock price low: ₹N/A.
How has the GLENMARK share price performed in the past year?
In April 2022, the huge pharmaceutical GLENMARK’s share price was in the region of Rs. 478. By June, it had dipped to the late 300 levels and never significantly went up till November. Highs were felt in December, and February 2023, and now the stock is at the 448 level.
Does GLENMARK pay dividends to its shareholders?
GLENMARK has a consistent track record of paying dividends to its loyal shareholders. In the recent past, the company has paid only final dividends, but interim dividends have been paid in the past as well.
What is the dividend yield of GLENMARK?
The dividend yield of GLENMARK is 0.56% (March 2022).
How does GLENMARK compare to its competitors in terms of share price?
Compared to popular competitors of GLENMARK, like Sun Pharma, Dr Reddy’s Labs, CIPLA, Torrent Pharma, Abbott India and others, the company’s share price is low at the moment (March 2023). Most of these companies have their share prices in the thousands, or late hundreds, whereas GLENMARK seems firmly poised on the mid-hundred mark.
What is the company's debt-to-equity ratio?
The company’s debt-to-equity ratio is 0.22.
What is the company's revenue and net income?
The revenue of GLENMARK is Rs. 3,463 crores (Q3 FY 2022-23) and the net income is Rs. 291 crores (December 2022).
How long has GLENMARK been in business?
GLENMARK started its foray into the pharmaceutical business with “Candid Cream”, a key dermatological drug, even in use now. The company started its business in 1977, headed by its Founder Emeritus, the late Gracias Saldanha.
What is the company's history of share price performance?
The share price of GLENMARK has been somewhat stable in the last 4-5 years, not showing much volatility as other pharma stocks have. In 2018, the share was in the region of the 500 mark, peaking at nearly 700 in 2019. Then, with a gradual and slow downward movement, it dipped to the region of 199 in 2020, only to slowly rise to 662 in 2021. Since then, it has been in the range of between 400-500 and is steady now.